PECAM1 and glioblastoma: Consistent with these findings, immunofluorescence analysis of surgical tumor specimens from human GBM patients showed diminished expression of VEGFR-2 in a certain part of CD31+ vasculatures in the tumors (Supplementary Fig. 3).